Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 May;4(3):305-10.
doi: 10.1242/dmm.000901.

Technical approaches for mouse models of human disease

Affiliations
Review

Technical approaches for mouse models of human disease

Monica J Justice et al. Dis Model Mech. 2011 May.

Abstract

The mouse is the leading organism for disease research. A rich resource of genetic variation occurs naturally in inbred and special strains owing to spontaneous mutations. However, one can also obtain desired gene mutations by using the following processes: targeted mutations that eliminate function in the whole organism or in a specific tissue; forward genetic screens using chemicals or transposons; or the introduction of exogenous transgenes as DNAs, bacterial artificial chromosomes (BACs) or reporter constructs. The mouse is the only mammal that provides such a rich resource of genetic diversity coupled with the potential for extensive genome manipulation, and is therefore a powerful application for modeling human disease. This poster review outlines the major genome manipulations available in the mouse that are used to understand human disease: natural variation, reverse genetics, forward genetics, transgenics and transposons. Each of these applications will be essential for understanding the diversity that is being discovered within the human population.

PubMed Disclaimer

Figures

None
An electronic version of this poster is available online.

Similar articles

Cited by

References

    1. Bestor T. H. (2005). Transposons reanimated in mice. Cell 122, 322–325 - PubMed
    1. Beutler B., Du X., Xia Y. (2007). Precis on forward genetics in mice. Nat. Immunol. 8, 659–664 - PubMed
    1. Branda C. S., Dymecki S. M. (2004). Talking about a revolution: the impact of site-specific recombinases on genetic analyses in mice. Dev. Cell 6, 7–28 - PubMed
    1. Capecchi M. R. (1989). The new mouse genetics: altering the genome by gene targeting. Trends Genet. 5, 70–76 - PubMed
    1. Carpinelli M. R., Hilton D. J., Metcalf D., Antonchuk J. L., Hyland C. D., Mifsud S. L., Di Rago L., Hilton A. A., Willson T. A., Roberts A. W., et al. (2004). Suppressor screen in Mpl-/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling. Proc. Natl. Acad. Sci. USA 101, 6553–6558 - PMC - PubMed

Substances